PACTR202403586718783尚未招募3 期
Effectiveness of multi-month dispensing of anti-TB drugs on treatment success among people with drug-susceptible TB aged =15 years on the standard 6-month anti-TB regimen in rural eastern Uganda
niversity of California Berkeley0 个研究点目标入组 260 人开始时间: 2024年2月24日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •1) TB focal persons with =1 year of work experience;
- •2) Other stakeholders with =3 years of work experience in TB;
- •3) People with TB on treatment for =4 months including the respective treatment supporters.
- •People with drug-susceptible PTB =15 years.
排除标准
- •1) Unreachable participants
- •1) People with TB who are very ill and require close clinical and laboratory monitoring or hospitalization;
- •2) People with PTB likely to migrate to another district/ or place during the study period;
- •3) Treated with anti-TB drugs for =2 months;
- •4) People with drug-resistant TB;
- •5) People with extrapulmonary TB since treatment duration exceeds 6 months.
研究者
相似试验
已完成
不适用
Study on reintroduction regimen of antituberculous therapy after developing of drug-induced hepatotoxicity (DIH)tuberculosisJPRN-UMIN000008069ational Center for Global Health and Medicine50
尚未招募
Unknown
To compare number of healthy household contacts aged between 6 to 18 years developing TB disease with tor without TB prophylactic therapy.CTRI/2023/04/052146Dr Poulomi Roy
进行中（未招募）
3 期
SURE: Short intensive treatment for children with tuberculous meningitisInfections and InfestationsTuberculous meningitisISRCTN40829906niversity College London369
进行中（未招募）
不适用
Effectiveness after 4 and 24 weeks and safety of tocilizumab in patients with active RA - TAMARA - Tocilizumab And DMARDs: Achievements in Rheumatoid ArthritisMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid ArthritisEUCTR2008-000105-11-DERoche Pharma AG
尚未招募
4 期
Prevention of tuberculosis (TB) with 3 months of isoniazid and rifapentine in people living with HIV and in child household contacts of TB patientsCTRI/2020/07/026305ICMRNational Institute for Research in TB